glp-1 regulations Medications: Everything You Need to Know Messaged provider re: GLP-1 discontinuation

Ongoing phase 3 clinical trials are testing the medication for weight management, osteoarthritis, NAFLD, cardiovascular risk reduction, type 2 diabetes, and moderate to severe obstructive sleep apnea in obese and overweight patients

Part of this was reflective of the fact that work on other intestinal peptides had proven disappointing

The average decline in HbA1c among treatment groups was 1.7 to 1.9 percentage points, more than double the placebo groups 0.8 percentage-point decrease

Possible effects include: Loose or excess skin Fatigue Hair thinning Muscle loss (if not strength training) Gallbladder issues with rapid loss Nutrient deficiencies if diet is poor Most risks are reduced with gradual weight loss, adequate protein, strength training, and medical supervision

*MUST BE NEW GLP-1 CLIENT WITH SLATE MEDSPA

What is a GLP-1 Patch